Who owns Trevi Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TRVI from SEC Form 13F filings across 219 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 219 institutions disclosed 149.0M shares of Trevi Therapeutics, Inc. worth $2.76B — about 95.2% of shares outstanding; the largest disclosed holder is NEA Management Company, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
219
13F holders
$2.76B
value, 2026 filers
95.2%
of shares outstanding (149.0M sh)
42
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of TRVI's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | NEA Management Company, LLC | 13.2M | $246.6M | 15.5% | 8.4% | 0.0% |
| 2 | FMR LLC | 12.6M | $234.3M | 0.0% | 8% | +56.3% |
| 3 | BlackRock, Inc. | 11.2M | $208.0M | 0.0% | 7.1% | +8.9% |
| 4 | Frazier Life Sciences Management, L.P. | 9.9M | $185.4M | 4.0% | 6.3% | 0.0% |
| 5 | WELLINGTON MANAGEMENT GROUP LLP | 5.7M | $106.0M | 0.0% | 3.6% | +9.5% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 5.5M | $103.1M | 0.0% | 3.5% | +11.1% |
| 7 | Vivo Capital, LLC | 5.1M | $95.0M | 8.7% | 3.3% | 0.0% |
| 8 | Woodline Partners LP | 4.1M | $76.1M | 0.2% | 2.6% | +307.8% |
| 9 | Vestal Point Capital, LP | 3.1M | $57.8M | 1.4% | 2% | +43.1% |
| 10 | MPM BIOIMPACT LLC | 3.1M | $57.3M | 3.5% | 2% | -6.8% |
| 11 | FRONTIER CAPITAL MANAGEMENT CO LLC | 3.1M | $57.3M | 0.5% | 2% | +54.0% |
| 12 | STATE STREET CORP | 3.0M | $56.5M | 0.0% | 1.9% | +13.6% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 2.9M | $54.6M | 0.0% | 1.9% | +5.4% |
| 14 | MARSHALL WACE, LLP | 2.7M | $49.9M | 0.0% | 1.7% | -32.6% |
| 15 | EVENTIDE ASSET MANAGEMENT, LLC | 2.7M | $49.6M | 0.7% | 1.7% | +1.4% |
| 16 | Rubric Capital Management LP | 2.5M | $46.7M | 0.4% | 1.6% | -32.5% |
| 17 | ALLIANCEBERNSTEIN L.P. | 2.4M | $28.1M | 0.0% | 1.5% | -17.2% |
| 18 | Artia Global Partners LP | 2.2M | $41.2M | 7.6% | 1.4% | +9.8% |
| 19 | ACORN CAPITAL ADVISORS, LLC | 2.1M | $40.0M | 10.9% | 1.4% | 0.0% |
| 20 | First Light Asset Management, LLCNEW | 2.1M | $39.1M | 2.4% | 1.3% | new |
| 21 | Pictet Asset Management Holding SA | 2.0M | $37.6M | 0.0% | 1.3% | +18.0% |
| 22 | Logos Global Management LP | 1.9M | $35.1M | 1.5% | 1.2% | -21.7% |
| 23 | Affinity Asset Advisors, LLC | 1.8M | $33.6M | 1.5% | 1.1% | -10.0% |
| 24 | EMERALD ADVISERS, LLC | 1.8M | $33.5M | 0.8% | 1.1% | -2.3% |
| 25 | Siren, L.L.C. | 1.8M | $33.3M | 0.7% | 1.1% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.